Caricamento...
Statin therapy in patients with cirrhosis
Cardiovascular disease is one of the leading causes of death among patients with cirrhosis and following liver transplantation. Although 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitors (‘statins’) reduce the risk of cardiovascular events, fears about hepatotoxicity have historically led to unde...
Salvato in:
| Pubblicato in: | Frontline Gastroenterol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMJ Publishing Group
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5369584/ https://ncbi.nlm.nih.gov/pubmed/28839820 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/flgastro-2014-100500 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|